Sodium/glucose cotransporter: Difference between revisions

Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(16 intermediate revisions by 3 users not shown)
Line 1: Line 1:
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''>
<StructureSection load='8hez' size='340' side='right' caption='Human glycosylated SGLT2 (cyan) complex with PDZK1-interacting protein (green), drug dapagliflozin and Na+ ion (PDB code [[8hez]])' scene='10/1042600/Cv/1'>
This is a default text for your page '''Sodium/glucose cotransporter'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
 
 
== Function ==
== Function ==


'''Sodium/glucose cotransporter''' (SGLT) is responsible for glucose absorption across membranes.  SGLT1 and SGLT2 which are expressed in different tissues, have similar active sites but differ in their non-active site structures.  SGLT1 is responsible of glucose absorption in the small intestine and SGLT2 in kidney<ref>PMID:26125647</ref>.
'''Sodium/glucose cotransporter''' (SGLT) is responsible for glucose absorption across membranes.  SGLT1 and SGLT2 which are expressed in different tissues, have similar active sites but differ in their non-active site structures.  '''SGLT1''' is responsible of glucose absorption in the small intestine and '''SGLT2''' in kidney<ref>PMID:26125647</ref>.


== Disease ==
== Disease ==
Line 13: Line 10:
== Relevance ==
== Relevance ==


SGLT2 inhibitors aid in hypertension, acute cardiac failure, bradycardia, acute pulmonary oedema, asthma, bronchitis and COPD<ref>PMID:36819350</ref>..
SGLT2 inhibitors aid in hypertension, acute cardiac failure, bradycardia, acute pulmonary oedema, asthma, bronchitis and COPD<ref>PMID:36819350</ref>.


== Structural highlights ==
== Structural highlights ==


This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
The drug Dapagliflozin contains a <scene name='10/1042600/Cv/5'>glucose moiety which stacks against residue Y290</scene> of SGLT2. The <scene name='10/1042600/Cv/6'>glucose moiety forms multiple H-bonds</scene> to SGLT2<ref>PMID:38057552</ref>. Water molecule is shown as red sphere.
 
See also:
*[[Canagliflozin]]
*[[Dapagliflozin]]
*[[Empagliflozin]]
==3D structures of sodium/glucose cotransporter==
 
[[Sodium/glucose cotransporter 3D structures]]


</StructureSection>
</StructureSection>
== References ==
== References ==
<references/>
<references/>
[[Category:Topic Page]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Jaime Prilusky, Alexander Berchansky